US Stock MarketDetailed Quotes

MRNA Moderna

Watchlist
  • 101.410
  • -0.590-0.58%
Close Apr 19 16:00 ET
  • 101.855
  • +0.445+0.44%
Post 19:41 ET
38.83BMarket Cap-8224P/E (TTM)

Moderna Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
-64.22%6.75B
-45.37%2.81B
-44.50%1.79B
-93.08%316M
-69.06%1.84B
6.42%18.88B
-25.90%5.15B
-33.32%3.22B
8.33%4.57B
240.79%5.94B
Operating revenue
-63.81%6.67B
-42.52%2.79B
-43.69%1.76B
-93.53%293M
-69.15%1.83B
4.30%18.44B
-29.46%4.86B
-35.39%3.12B
7.50%4.53B
239.93%5.93B
Cost of revenue
-13.35%4.69B
-51.56%929M
103.73%2.24B
-47.07%731M
-22.12%792M
106.95%5.42B
101.47%1.92B
52.35%1.1B
84.13%1.38B
426.94%1.02B
Gross profit
-84.69%2.06B
-41.69%1.88B
-121.42%-454M
-113.03%-415M
-78.75%1.05B
-10.98%13.46B
-46.12%3.23B
-48.38%2.12B
-8.08%3.19B
217.61%4.92B
Operating expense
55.98%6.3B
13.75%1.88B
63.31%1.56B
96.75%1.45B
102.87%1.41B
121.56%4.04B
181.26%1.65B
73.77%954M
83.13%738M
145.07%696M
Selling and administrative expenses
36.84%1.55B
25.33%470M
58.99%442M
57.35%332M
13.81%305M
99.65%1.13B
86.57%375M
65.48%278M
74.38%211M
248.05%268M
Research and development costs
47.04%4.85B
16.10%1.41B
41.46%1.16B
61.69%1.15B
104.15%1.13B
65.49%3.3B
86.88%1.21B
57.39%820M
68.65%710M
38.15%554M
Other operating expenses
75.77%-94M
-96.92%2M
69.44%-44M
84.70%-28M
80.95%-24M
47.21%-388M
124.81%65M
-2.86%-144M
-31.65%-183M
35.05%-126M
Operating profit
-145.00%-4.24B
-99.62%6M
-272.56%-2.01B
-176.30%-1.87B
-108.66%-366M
-29.15%9.42B
-70.79%1.58B
-67.23%1.17B
-20.08%2.45B
233.89%4.23B
Net non-operating interest income expense
123.98%383M
25.97%97M
90.00%95M
160.00%91M
1,011.11%100M
850.00%171M
305.26%77M
50M
1,850.00%35M
800.00%9M
Non-operating interest income
110.50%421M
18.39%103M
81.03%105M
160.00%104M
626.67%109M
1,011.11%200M
1,142.86%87M
1,350.00%58M
1,233.33%40M
275.00%15M
Non-operating interest expense
31.03%38M
-40.00%6M
25.00%10M
160.00%13M
50.00%9M
--29M
--10M
100.00%8M
0.00%5M
100.00%6M
Other net income (expense)
-437.50%-86M
-1,550.00%-33M
-4,200.00%-41M
437.50%27M
-457.14%-39M
44.83%-16M
89.47%-2M
116.67%1M
-366.67%-8M
0.00%-7M
Gain on sale of security
-260.00%-72M
-1,000.00%-22M
-825.00%-37M
375.00%22M
-483.33%-35M
---20M
---2M
---4M
-500.00%-8M
---6M
Other non- operating income (expenses)
-450.00%-14M
---11M
-180.00%-4M
--5M
-300.00%-4M
113.79%4M
--0
183.33%5M
----
85.71%-1M
Income before tax
-141.17%-3.94B
-95.77%70M
-260.89%-1.96B
-170.70%-1.75B
-107.21%-305M
-27.93%9.58B
-69.41%1.66B
-65.74%1.22B
-19.23%2.47B
235.63%4.23B
Income tax
-36.36%772M
-177.37%-147M
860.92%1.67B
-233.21%-369M
-167.13%-384M
12.00%1.21B
-64.94%190M
-20.55%174M
-2.12%277M
1,366.67%572M
Net income
-156.37%-4.71B
-85.19%217M
-448.03%-3.63B
-162.81%-1.38B
-97.84%79M
-31.47%8.36B
-69.91%1.47B
-68.71%1.04B
-20.97%2.2B
199.51%3.66B
Net income continuous Operations
-156.37%-4.71B
-85.19%217M
-448.03%-3.63B
-162.81%-1.38B
-97.84%79M
-31.47%8.36B
-69.91%1.47B
-68.71%1.04B
-20.97%2.2B
199.51%3.66B
Minority interest income
Net income attributable to the parent company
-156.37%-4.71B
-85.19%217M
-448.03%-3.63B
-162.81%-1.38B
-97.84%79M
-31.47%8.36B
-69.91%1.47B
-68.71%1.04B
-20.97%2.2B
199.51%3.66B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-156.37%-4.71B
-85.19%217M
-448.03%-3.63B
-162.81%-1.38B
-97.84%79M
-31.47%8.36B
-69.91%1.47B
-68.71%1.04B
-20.97%2.2B
199.51%3.66B
Basic earnings per share
-158.00%-12.33
-85.04%0.57
-456.93%-9.53
-165.23%-3.62
-97.80%0.2
-29.86%21.26
-68.33%3.81
-67.71%2.67
-19.91%5.55
198.03%9.09
Diluted earnings per share
-161.28%-12.33
-84.76%0.55
-476.68%-9.53
-169.08%-3.62
-97.79%0.19
-28.88%20.12
-68.02%3.61
-67.14%2.53
-18.89%5.24
202.11%8.58
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue -64.22%6.75B-45.37%2.81B-44.50%1.79B-93.08%316M-69.06%1.84B6.42%18.88B-25.90%5.15B-33.32%3.22B8.33%4.57B240.79%5.94B
Operating revenue -63.81%6.67B-42.52%2.79B-43.69%1.76B-93.53%293M-69.15%1.83B4.30%18.44B-29.46%4.86B-35.39%3.12B7.50%4.53B239.93%5.93B
Cost of revenue -13.35%4.69B-51.56%929M103.73%2.24B-47.07%731M-22.12%792M106.95%5.42B101.47%1.92B52.35%1.1B84.13%1.38B426.94%1.02B
Gross profit -84.69%2.06B-41.69%1.88B-121.42%-454M-113.03%-415M-78.75%1.05B-10.98%13.46B-46.12%3.23B-48.38%2.12B-8.08%3.19B217.61%4.92B
Operating expense 55.98%6.3B13.75%1.88B63.31%1.56B96.75%1.45B102.87%1.41B121.56%4.04B181.26%1.65B73.77%954M83.13%738M145.07%696M
Selling and administrative expenses 36.84%1.55B25.33%470M58.99%442M57.35%332M13.81%305M99.65%1.13B86.57%375M65.48%278M74.38%211M248.05%268M
Research and development costs 47.04%4.85B16.10%1.41B41.46%1.16B61.69%1.15B104.15%1.13B65.49%3.3B86.88%1.21B57.39%820M68.65%710M38.15%554M
Other operating expenses 75.77%-94M-96.92%2M69.44%-44M84.70%-28M80.95%-24M47.21%-388M124.81%65M-2.86%-144M-31.65%-183M35.05%-126M
Operating profit -145.00%-4.24B-99.62%6M-272.56%-2.01B-176.30%-1.87B-108.66%-366M-29.15%9.42B-70.79%1.58B-67.23%1.17B-20.08%2.45B233.89%4.23B
Net non-operating interest income expense 123.98%383M25.97%97M90.00%95M160.00%91M1,011.11%100M850.00%171M305.26%77M50M1,850.00%35M800.00%9M
Non-operating interest income 110.50%421M18.39%103M81.03%105M160.00%104M626.67%109M1,011.11%200M1,142.86%87M1,350.00%58M1,233.33%40M275.00%15M
Non-operating interest expense 31.03%38M-40.00%6M25.00%10M160.00%13M50.00%9M--29M--10M100.00%8M0.00%5M100.00%6M
Other net income (expense) -437.50%-86M-1,550.00%-33M-4,200.00%-41M437.50%27M-457.14%-39M44.83%-16M89.47%-2M116.67%1M-366.67%-8M0.00%-7M
Gain on sale of security -260.00%-72M-1,000.00%-22M-825.00%-37M375.00%22M-483.33%-35M---20M---2M---4M-500.00%-8M---6M
Other non- operating income (expenses) -450.00%-14M---11M-180.00%-4M--5M-300.00%-4M113.79%4M--0183.33%5M----85.71%-1M
Income before tax -141.17%-3.94B-95.77%70M-260.89%-1.96B-170.70%-1.75B-107.21%-305M-27.93%9.58B-69.41%1.66B-65.74%1.22B-19.23%2.47B235.63%4.23B
Income tax -36.36%772M-177.37%-147M860.92%1.67B-233.21%-369M-167.13%-384M12.00%1.21B-64.94%190M-20.55%174M-2.12%277M1,366.67%572M
Net income -156.37%-4.71B-85.19%217M-448.03%-3.63B-162.81%-1.38B-97.84%79M-31.47%8.36B-69.91%1.47B-68.71%1.04B-20.97%2.2B199.51%3.66B
Net income continuous Operations -156.37%-4.71B-85.19%217M-448.03%-3.63B-162.81%-1.38B-97.84%79M-31.47%8.36B-69.91%1.47B-68.71%1.04B-20.97%2.2B199.51%3.66B
Minority interest income
Net income attributable to the parent company -156.37%-4.71B-85.19%217M-448.03%-3.63B-162.81%-1.38B-97.84%79M-31.47%8.36B-69.91%1.47B-68.71%1.04B-20.97%2.2B199.51%3.66B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -156.37%-4.71B-85.19%217M-448.03%-3.63B-162.81%-1.38B-97.84%79M-31.47%8.36B-69.91%1.47B-68.71%1.04B-20.97%2.2B199.51%3.66B
Basic earnings per share -158.00%-12.33-85.04%0.57-456.93%-9.53-165.23%-3.62-97.80%0.2-29.86%21.26-68.33%3.81-67.71%2.67-19.91%5.55198.03%9.09
Diluted earnings per share -161.28%-12.33-84.76%0.55-476.68%-9.53-169.08%-3.62-97.79%0.19-28.88%20.12-68.02%3.61-67.14%2.53-18.89%5.24202.11%8.58
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg